NeuroSpectrum Insights Inc.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
IPO Details
Announcement date
Jun 20, 2025
−16.71 USD
−10.57 M USD
0.00 USD
4.14 M
About NeuroSpectrum Insights Inc.
Sector
Industry
CEO
Janet Huffman
Website
Headquarters
Sarasota
Founded
1996
Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Sarasota, FL.
Related stocks
Frequently Asked Questions
IPO (initial public offering) is the process through which a private company offers its shares to the public for the first time to raise equity capital from a broader base of public investors.
The share price is determined by one or more underwriters, depending on the size of the company. When setting the price, underwriters consider several key factors: the company's current valuation, its future growth potential, associated risks, and how they are compensated, as well as supply and demand and current public market conditions.
An underwriter tries to balance the IPO price — make it high enough to generate sufficient capital for the company, but low enough to attract investors.
Once these factors are evaluated, the company's valuation is divided by the total number of shares, resulting in the price per share.
An underwriter tries to balance the IPO price — make it high enough to generate sufficient capital for the company, but low enough to attract investors.
Once these factors are evaluated, the company's valuation is divided by the total number of shares, resulting in the price per share.
Private companies are owned by a small circle of people: founders, executive management, and private investors. They are closed to public ownership, and their shares can't be bought on exchanges. Conversely, public companies can be owned by members of the public who purchase stocks on the market after the company's IPO.
Buying such stocks can be a good idea if the company has strong fundamentals and growth potential. Investors can benefit from the company's performance. Buying an IPO also allows investors to invest in a company at its initial market entry, which gives them a timing advantage before the company reaches its full potential.
However, it's crucial to bear in mind that IPOs, like any other stocks, can be highly volatile. In some instances, companies may be overhyped, leading to an inflated price that could plummet once the initial excitement wanes. Additionally, unlike established companies, IPOs often lack extensive historical data and performance records, making it challenging to fully assess their financial health and business model. This, in turn, can result in potential losses for investors.
The bottom line is that NeuroSpectrum Insights Inc. may be a good investment, but you need to do a thorough research before making a decision.
However, it's crucial to bear in mind that IPOs, like any other stocks, can be highly volatile. In some instances, companies may be overhyped, leading to an inflated price that could plummet once the initial excitement wanes. Additionally, unlike established companies, IPOs often lack extensive historical data and performance records, making it challenging to fully assess their financial health and business model. This, in turn, can result in potential losses for investors.
The bottom line is that NeuroSpectrum Insights Inc. may be a good investment, but you need to do a thorough research before making a decision.
Companies usually go public to raise capital with the aim of expanding and providing liquidity to early shareholders, and NeuroSpectrum Insights Inc. is not an exception here. An IPO provides a company with a significant influx of funds, which can be used for funding new projects, paying down debt, providing returns to early shareholders, and other purposes.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE NeuroSpectrum Insights Inc. stocks will be traded under the ticker "OGEN".
Like other stocks, NeuroSpectrum Insights Inc. shares will be traded on stock exchanges, e.g., Nasdaq, NYSE, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NeuroSpectrum Insights Inc. stocks when the company goes public right from TradingView charts — choose your broker and connect to your account.
As of Nov 21, 2025, the company has 3 employees. See our rating of the largest employees — is NeuroSpectrum Insights Inc. on this list?
Yes, you can track NeuroSpectrum Insights Inc. financials in yearly and quarterly reports right on TradingView.
OGEN net income for the last quarter is −3.07 M USD, while the quarter before that showed −2.27 M USD of net income which accounts for −34.97% change. Track more NeuroSpectrum Insights Inc. financial stats to get the full picture.